Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Placebo Controlled, Phase II Study of Aerosolized tgAAVCF for the Treatment of Cystic Fibrosis

NCT00073463 is registered in ClinicalTrials.gov with Targeted Genetics Corporation as lead sponsor.

NCT NCT00073463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00073463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Placebo Controlled, Phase II Study of Aerosolized tgAAVCF for the Treatment of Cystic Fibrosis
Lead sponsor
Targeted Genetics Corporation
Phase
Phase 2/3
Overall status
Terminated
Start date
June 30, 2003
Completion date
October 31, 2005
Enrollment
100
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis